GPT and metabolic dysfunction-associated steatotic liver disease: In the model adjusted for sex and age (Model I), the core outcome of the association between the ALT/AST ratio and NAFLD risk did not change significantly (adjusted HRs [aHRs]: 2.61, 95% CI: 2.48, 2.76).